The UK SmPCs for Wegovy (semaglutide 2.4 mg) and Mounjaro (tirzepatide), available via the Electronic Medicines Compendium (EMC), provide detailed information on GI adverse reactions and class-related warnings such as pancreatitis and gallbladder disease
These differences were not seen after matching (Table 1)
This is why properly formulated copper peptides rarely cause the oxidative damage that free copper might
Monitoring Your Progress Successful semaglutide treatment requires careful monitoring of both your weight loss progress and how well you're tolerating each dose
A steady, controlled rate of weight loss gives your skin the necessary time to adapt, minimizing the dramatic deflation that leads to pronounced facial hollowing
Government Support and Policy Initiatives Recognizing the need for accessible obesity treatments, India plans to offer incentives under the Production Linked Incentive (PLI) scheme to promote the local manufacturing of GLP-1 drugs in 2026